The Central Bank of the UAE (CBUAE) has sent a binding circular to every company selling health insurance in the country, Gulf News reported on 15 November. Insurers must include the removal and transplantation of human organs and tissues in their policies and endorsements, under all health insurance schemes in the UAE.
The cover applies to donors, living or deceased, and to recipients. It takes in checks before the procedure, the surgery, care and follow-up after discharge, and treatment of complications. Khaleej Times reported that the rules require complications to be treated 'irrespective of when such complications arise or are detected'.
The circular puts into effect Cabinet Resolution No. 61 of 2026, the executive regulations of Federal Decree-Law No. 25 of 2023 on organ and tissue donation and transplantation. The regulations were published in the Official Gazette on 30 April 2026. Article 9, which sets the insurance duty, took effect on 31 October 2026 after a six-month transition period for insurers.
Middle East Insurance Review said complications such as immune rejection and secondary infections can appear long after a patient leaves hospital, which is why the rules set no time limit. The regulations also create a national registry of donation wishes linked to the UAE digital identity system and require licences for transplant hospitals and surgeons, Khaleej Times reported.
None of the reports gives the circular's number or an estimate of the cost to insurers.
Read the source
Gulf News · News publisher · 15 Nov 2026. This is an original brief based on the linked publication. Company statements and forecasts are attributed to their source.



